In a significant development, Syndax Pharmaceuticals Inc. has announced a new clinical study titled ‘A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Revumenib in Combination With ...

Discover how HSBC's $1.9 billion fine exposed severe compliance failures and forced reforms in their anti-money laundering controls involving Mexican drug cartels.

South Africa' s recent removal from the FATF greylist marks not an end but a beginning of intensified regulatory oversight.

As corruption scandals involving politically exposed persons (PEPs) dominate national discourse, one critical institution has largely escaped meaningful scrutiny: the banking sector. These are the ...

Detailed price information for Daiichi Sankyo Ltd (DSKYF) from The Globe and Mail including charting and trades.